Suppr超能文献

相似文献

1
BRD4 Regulates Breast Cancer Dissemination through Jagged1/Notch1 Signaling.
Cancer Res. 2016 Nov 15;76(22):6555-6567. doi: 10.1158/0008-5472.CAN-16-0559. Epub 2016 Sep 20.
4
Hsa-miR-599 inhibits breast cancer progression via BRD4/Jagged1/Notch1 axis.
J Cell Physiol. 2022 Jan;237(1):523-531. doi: 10.1002/jcp.30548. Epub 2021 Aug 20.
5
6
BET Proteins Exhibit Transcriptional and Functional Opposition in the Epithelial-to-Mesenchymal Transition.
Mol Cancer Res. 2018 Apr;16(4):580-586. doi: 10.1158/1541-7786.MCR-17-0568. Epub 2018 Feb 7.
8
Systematic analysis of the BET family in adrenocortical carcinoma: The expression, prognosis, gene regulation network, and regulation targets.
Front Endocrinol (Lausanne). 2023 Jan 30;14:1089531. doi: 10.3389/fendo.2023.1089531. eCollection 2023.
9
Brucine inhibits bone metastasis of breast cancer cells by suppressing Jagged1/Notch1 signaling pathways.
Chin J Integr Med. 2017 Feb;23(2):110-116. doi: 10.1007/s11655-016-2647-2. Epub 2016 Dec 29.

引用本文的文献

1
Beyond small molecules: advancing MYC-targeted cancer therapies through protein engineering.
Transcription. 2025 Feb;16(1):67-85. doi: 10.1080/21541264.2025.2453315. Epub 2025 Jan 29.
2
BRD4: an effective target for organ fibrosis.
Biomark Res. 2024 Aug 30;12(1):92. doi: 10.1186/s40364-024-00641-6.
3
BRD4-specific PROTAC inhibits basal-like breast cancer partially through downregulating KLF5 expression.
Oncogene. 2024 Sep;43(39):2914-2926. doi: 10.1038/s41388-024-03121-1. Epub 2024 Aug 20.
4
Prioritizing drug targets by perturbing biological network response functions.
PLoS Comput Biol. 2024 Jun 27;20(6):e1012195. doi: 10.1371/journal.pcbi.1012195. eCollection 2024 Jun.
5
Sequential Inhibition of PARP and BET as a Rational Therapeutic Strategy for Glioblastoma.
Adv Sci (Weinh). 2024 Aug;11(30):e2307747. doi: 10.1002/advs.202307747. Epub 2024 Jun 19.
8
Targeting BRD4: Potential therapeutic strategy for head and neck squamous cell carcinoma (Review).
Oncol Rep. 2024 Jun;51(6). doi: 10.3892/or.2024.8733. Epub 2024 Apr 12.
10
Effects of bromodomain and extra-terminal inhibitor JQ1 and interleukin-6 on breast cancer cells.
Mol Biol Rep. 2023 Oct;50(10):8319-8328. doi: 10.1007/s11033-023-08718-5. Epub 2023 Aug 17.

本文引用的文献

1
Response and resistance to BET bromodomain inhibitors in triple-negative breast cancer.
Nature. 2016 Jan 21;529(7586):413-417. doi: 10.1038/nature16508. Epub 2016 Jan 6.
2
Notch signaling: an emerging therapeutic target for cancer treatment.
Cancer Lett. 2015 Dec 1;369(1):20-7. doi: 10.1016/j.canlet.2015.07.048. Epub 2015 Sep 1.
5
BRD4 inhibitor inhibits colorectal cancer growth and metastasis.
Int J Mol Sci. 2015 Jan 16;16(1):1928-48. doi: 10.3390/ijms16011928.
6
Exosome transfer from stromal to breast cancer cells regulates therapy resistance pathways.
Cell. 2014 Oct 23;159(3):499-513. doi: 10.1016/j.cell.2014.09.051.
7
The notch ligand JAGGED1 as a target for anti-tumor therapy.
Front Oncol. 2014 Sep 25;4:254. doi: 10.3389/fonc.2014.00254. eCollection 2014.
10
Blockade of oncogenic IκB kinase activity in diffuse large B-cell lymphoma by bromodomain and extraterminal domain protein inhibitors.
Proc Natl Acad Sci U S A. 2014 Aug 5;111(31):11365-70. doi: 10.1073/pnas.1411701111. Epub 2014 Jul 21.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验